Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany

Clinical trial NCT00406354 · COMPLETED

Trial details

NCT number: NCT00406354
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Oppositional Defiant Disorder

Start date: 2006-11-01
Primary completion: 2009-01-01
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.